ICICI Lombard General Insurance Company Ltd

The transcript does not mention any current or future plans for fundraising through debt or equity. Specific points: - No reference to raising capital via equity or debt during the call. - Discussion primarily focused on operational performance, loss ratios, investment income, and growth strategies. - No disclosures related to new fundraising initiatives were made by the management. Hence, based on the Q2 & H1 FY2024 earnings call transcript, ICICI Lombard General Insurance Co. Ltd. has not indicated any plans for new fundraising through debt or equity at this time.

- ICICI Lombard is continuing to make investments in building distribution, especially in the health agency channel. - They are investing in technology, including the transformation of their core system, expected to be a key driver for future growth as a digitally empowered insurance company. - Investments are ongoing in digital capabilities, such as the IL TakeCare app, which has seen a 3.7x increase in premium sourced year-on-year, driving both volume and value growth. - The company is also focused on cost calibration and capability building in claims and expense management. - While expense ratios are being managed carefully, investment in distribution, technology, and transformation projects will continue, which may moderate immediate expense ratio improvements. - The strategic partnership with ICICI Pru Life to offer combo products leverages distribution capabilities, indicating a strategic investment in new product offerings through joint distribution channels.

- The company expects to end FY2024 with high-teens percentage growth in sales/revenue, in line with positive market conditions. - Motor segment growth is cautiously pursued with focus on profitable pools such as new private cars and two-wheelers, with overall motor GDPI growing 10.9% in Q2 FY2024. - Health segment remains the fastest growing, with retail health growing 19.0% and group health 20.6% in Q2 FY2024, supported by investments in retail health agency distribution. - Digital initiatives like IL TakeCare app are driving volume growth, contributing 6.0% to overall GDPI with a 3.7x year-on-year increase in premium sourced via the app. - Emerging markets (outside top 40 cities) are targeted for growth with dedicated senior management focus. - The company aims to outperform the market growth rate by 100-200 basis points through calibrated pricing, customer engagement, and portfolio rebalancing.

- The company expects to continue profitable growth with sustainable value creation and safeguarding policyholders' interests. - Profit Before Tax (PBT) grew 19.4% in H1 FY2024 and 25.3% in Q2 FY2024, with Profit After Tax (PAT) growth adjusted for tax reversals at 19.2% (H1 FY24) and 24.8% (Q2 FY24). - Return on Average Equity (ROAE) stands at 18% for H1 FY24 vs. 19.9% in H1 FY23; slight moderation expected but remains strong. - Management maintains guidance for a combined ratio target of 102% by the end of FY2025 to improve underwriting profitability. - Investment income outperforming past periods but expects normalization; no specific yield guidance provided, though investment leverage remains stable. - Business growth guided to continue in high-teens percentage range for the full year, with expected market share gains and expense management focus. - Earnings leverage expected from calibrated Motor portfolio and continued digital initiatives enhancing growth and cross-sell.

The provided transcript of ICICI Lombard General Insurance Co. Ltd.'s Q2 & H1 FY2024 earnings call does not contain any information regarding current or expected order book or pending orders. The discussion primarily revolves around: - Financial performance and growth figures, - Loss ratios and underwriting details for motor and health insurance segments, - Market strategies including OEM and non-OEM focus, - Digital initiatives like the IL TakeCare app, - Industry trends and competition, and - Expense management and investment income. No details related to order book or pending orders are mentioned in the transcript provided.